$TCOM

Rosen Law Firm files securities class action against biopharmaceutical company Aldeyra Therapeutics, alleging false statements. Lead plaintiff deadline: May 29, 2026.

Rosen Law Firm filed securities class action against Trip.com over alleged false statements on regulatory risks. Investors have until May 11, 2026 to become lead plaintiffs.

Trip.com faces class action lawsuit alleging failure to disclose regulatory risks tied to monopolistic practices. Investors have until May 11, 2026 to join.

Rosen Law Firm urges $PSIX investors to join securities class action lawsuit before May 19, 2026 deadline. Eligible shareholders may recover losses from alleged securities violations.

Rosen Law Firm filed a securities class action against $TCOM alleging false statements regarding monopolistic practices and regulatory risks. Investors have until May 11, 2026 to participate.

Class action lawsuit filed against $TCOM alleging securities fraud over false regulatory risk statements from April 2024 to January 2026.

Trip.com faces securities fraud lawsuit after China's antitrust regulator probed alleged monopolistic practices. Stock fell 19.4% in January 2026.

Trip.com faces class action lawsuit over undisclosed regulatory risks after 17% stock drop following Chinese antitrust investigation into its AI pricing tool.

Rosen Law Firm filed class action lawsuit against $ALDX alleging false statements. Investors with $100K+ losses urged to join before deadline.

Rosen Law Firm files securities class action against Trip.com Group Limited ($TCOM), urging investors with losses exceeding $100K to secure counsel before May 11, 2026 deadline.

Rosen Law Firm launches securities class action against Trip.com ($TCOM) over alleged false regulatory risk disclosures. Lead plaintiff deadline: May 11, 2026.

Robbins LLP filed class action against $TCOM for allegedly concealing antitrust risks. Stock dropped 19.4% after January 2026 antitrust probe disclosure.

Trip.com ($TCOM) faces securities lawsuit alleging misleading disclosure about AI pricing tool regulatory risks. Stock fell 17% after Chinese regulators opened investigation.

Trip.com faces class action lawsuit alleging false regulatory risk disclosures regarding monopolistic practices. Lead plaintiff deadline set for May 11, 2026.

Trip.com faces securities fraud lawsuit following SAMR antitrust investigation into monopolistic practices. Stock declined 19.4% post-disclosure; investors have until May 2026 to join action.

Rosen Law Firm initiates securities class action against $TCOM for allegedly understating regulatory risks from monopolistic practices. May 11 deadline for investors.

Trip.com faces class action lawsuit alleging false statements about regulatory risks tied to monopolistic practices during April 2024-January 2026 period.

Securities lawsuit filed against $TCOM for allegedly concealing antitrust investigation by Chinese regulators. May 11 deadline for lead plaintiff status.

Trip.com stock crashed 17% after China's antitrust probe into misleading disclosures about its AI price adjustment tool. Company subsequently shut down the tool and co-founders resigned.

Class action lawsuit filed against $TCOM over alleged concealment of Chinese regulatory investigation into monopolistic practices. Stock plunged 17.05% following disclosure.